About this trial
The primary aim of this monocentric randomised controlled study is to evaluate the impact of using GAS to maintain the functional abilities of children and adolescents undergoing TCSE. The secondary aims include evaluating parents' and adolescents' perceived changes in the subject's functional abilities from the moment of stem cell transplantation unit (SCTU) admission to subsequent follow-ups. Another secondary aim is to evaluate the achievement of functional goals as defined by GAS in the experimental group (EG). Other aims include investigating the feasibility of the exercise program and the rehabilitation counselling indications in both groups, as well as the effectiveness of the two interventions and GAS use in the EG.
Eligibility criteria
Qualifiers
age between 6 months - 17 years and 11 months
diagnosis of oncological or hematological disease undergoing HSCT
No specific rehabilitation treatment ongoing at the moment of recruitment
Written informed consent from patient or parents/legal representative, and age-appropriate assent.
Disqualifiers
Patients that are not able and willing to comply with study visits and procedures.
Trial design
Treatments tested in this trial
- GAS group
- control group